New York Life Investment Management LLC Collegium Pharmaceutical, Inc Transaction History

New York Life Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$31.23 - $40.91 $170,671 - $223,573	-5,465 Reduced 37.96%	8,930 $346,000
Q4 2023 Feb 05, 2024	SELL	$21.16 - $30.8 $9,437 - $13,736	-446 Reduced 3.01%	14,395 $443,000
Q3 2023 Nov 07, 2023	SELL	$21.23 - $24.28 $49,635 - $56,766	-2,338 Reduced 13.61%	14,841 $331,000
Q2 2023 Aug 04, 2023	SELL	$21.06 - $24.0 $52,755 - $60,120	-2,505 Reduced 12.73%	17,179 $369,000
Q1 2023 May 08, 2023	SELL	$23.0 - $29.88 $188,117 - $244,388	-8,179 Reduced 29.35%	19,684 $472,000
Q4 2022 Feb 10, 2023	BUY	$16.14 - $23.55 $50,744 - $74,041	3,144 Added 12.72%	27,863 $646,000
Q3 2022 Nov 10, 2022	BUY	$15.46 - $20.1 $28,044 - $36,461	1,814 Added 7.92%	24,719 $396,000
Q2 2022 Aug 12, 2022	BUY	$14.22 - $20.88 $325,709 - $478,256	22,905 New	22,905 $406,000

249

36.2M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.11B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on New York Life Investment Management LLC with notifications on news.